A chronic low dose of 9-tetrahydrocannabinol (THC) restores cognitive function in old mice
The effect was due to on-target inhibition of GPX4 rather than reduction of GSH levels, as, contrary to the marked reduction in GSH observed with L-buthionine-sulfoximine (BSO), we observed only a small reduction with SCLA2 at 10 M and no change at 1 M (Extended Data Fig
This 30mL multi-dose vial contains 0.9% benzyl alcohol as a preservative, helping maintain sterility for repeated use while ensuring reliable performance
That being said, um, I wouldn't be surprised if pharma, if they found that there was some benefit to this, they'll probably tweak it, add a couple amino acids here and there, find another proprietary version of this, and then sell that as the next great
NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying